Shilpa Medicare reported a sharp rise in earnings for the fourth quarter, driven by strong revenue growth, improved operating performance, and a favourable one-time gain.
The pharmaceutical company posted a consolidated net profit of ₹108 crore in Q4FY26, compared to ₹14.5 crore in the corresponding quarter last year, marking a massive year-on-year surge of nearly 645%.
Revenue from operations rose 32% YoY to ₹437 crore, against ₹331 crore reported in the same period last year, reflecting healthy business momentum across segments.
The company’s EBITDA climbed 49.6% YoY to ₹119.7 crore from ₹80 crore in Q4FY25. EBITDA margins also improved significantly to 27.4%, compared with 24.1% in the year-ago quarter, indicating better operational efficiency and cost management.
Shilpa Medicare’s quarterly performance was further supported by a one-time gain of ₹25 crore during the quarter, compared to a one-time loss of ₹30.6 crore reported in the same quarter last year.
The strong quarterly numbers highlight improved profitability and margin expansion for Shilpa Medicare, aided by operational growth and exceptional gains during the quarter.